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Abstract
Non-coding DNA conservation across species has been often used as a predictor for transcriptional enhancer activity.
However, only a few systematic analyses of the function of these highly conserved non-coding regions (HCNRs) have been
performed. Here we use zebrafish transgenic assays to perform a systematic study of 113 HCNRs from human chromosome
16. By comparing transient and stable transgenesis, we show that the first method is highly inefficient, leading to 40% of
false positives and 20% of false negatives. When analyzed in stable transgenic lines, a great majority of HCNRs were active in
the central nervous system, although some of them drove expression in other organs such as the eye and the excretory
system. Finally, by testing a fraction of the HCNRs lacking enhancer activity for in vivo insulator activity, we find that 20% of
them may contain enhancer-blocking function. Altogether our data indicate that HCNRs may contain different types of cis-
regulatory activity, including enhancer, insulators as well as other not yet discovered functions.
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Introduction
A decade after the release of the first human genome’s draft, we
do not understand most of the information encoded in these 3
Gigabases of DNA. The degenerated triplets that encode the
composition of the proteins impose a constraint in the random
potential of DNA sequences which facilitates the prediction of
most protein-coding genes. In addition, transcription expression
analysis have led the scientific community to extensive knowledge
on RNA levels and alternative splicing in different tissues and
developmental stages on a variety of animal models. Thus, we can
probably assume a successful annotation of most of the protein-
coding genes of the higher organisms sequenced so far. However,
this knowledge is in striking contrast to our capacity in predicting
the existence of cis-regulatory elements, which are embedded in
the remaining 98% of the genome. Thus, number, behavior and
nature of most regulatory elements governing gene transcription
remains poorly determined.
The comparison of all the sequenced vertebrate model organisms
revealed the presence of many highly conserved non-coding regions
(HCNRs) present in vertebrate genomes [1,2,3]. Most of these
regions are associated with genes with roles in body patterning and
organ morphogenesis [1,3]. Functional studies using transgenic
assays in mouse, Xenopus and zebrafish carried out by various
groups, indicate that a significant fraction of the HCNRs so far
analyzed behave as enhancers in functional assays. These enhancers
likely activate the expression of genes essential for embryonic
development in specific embryonic domains (see for example
[1,4,5,6,7]. Based on these observations, it has been speculated that
the approximately 3000 HCNRs present in all vertebrates likely
contain regulatory elements essential for the basic vertebrate body
plan [8,9]. Other initiatives to identify potential cis-regulatory
elements are based in chromatin immunoprecipitation experiments
coupled to massive sequencing using both transcription factors
and epigenetic marks [10,11,12,13,14,15,16,17,18,19]. These
studies have enormously expanded the collection of candidate
cis-regulatory elements present in the vertebrate and invertebrate
genomes. These huge amount of potential cis-regulatory already
available, and continuously growing, need to be validated in animal
model systems in order to explore their precise in vivo temporal and
spatial activity. Efforts in this direction are been done using the
mouse as a model system [5,20,21]. In these studies more than 1000
potential cis-regulatory elements have been assayed by transient
transgenic assays in mouse embryos at a single developmental stage.
These have lead to the identification of multiple tissue-specific
enhancers, many of them evolutionary conserved at the sequence
level. These enhancer assays in transient murine transgenics are
laborious and expensive and usually limited to a single develop-
mental time point, and therefore not particularly suited for large
scale screens. Xenopus and zebrafish have been used as alternative
models to systematically evaluate in vivo de enhancer activity of
potential cis-regulatory elements [1,6,7,22,23,24]. The develop-
ment of Tol2 mediated transgenesis in zebrafish [25] the trans-
parency of its embryo and larvae, which is perfect for imaging, and
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model for the in vivo analysis of cis-regulatory element activity
[26,27]. Nevertheless, since the generation of stable transgenic lines
in zebrafish is time consuming, most middle to large-scale enhancer
screenings in zebrafish are based on transient F0 studies [6,7,24,
28,29,30,31]. Assays in F0 (i.e. injected) zebrafish have the strong
advantage of being a medium throughput approach, but since the
integration of the reporter construct occurs only in some cells of the
injected embryo, the activity of the potential enhancer is mosaic
therefore revealing a fraction of the territory where the regulatory
element under evaluation is potentially active. Moreover, enhancer
activity can be affected by the regulatory elements in the vicinity of
the insertion point (what is commonly known as ‘‘position effect’’).
Recently, the ZED vector was developed [32]. The two major
characteristics of this vector is that the reporter cassette is flanked by
insulators that reduce the position effect, and that the vector
contains a positive control of transgenesis that allows to monitor the
efficiently of integration of the transgenic construct both in transient
injected and stable transgenic embryos [32].
Here we use the ZED vector to evaluate the activity of more than a
hundred HCNR from the human genome, first in transient assays
and later in stable transgenic assays in zebrafish. Then, animals
showing reporter activity in F0 were grown to adulthood to establish
stable transgenic lines in which the enhancer activity was charac-
terized in detail and at different developmental stages. In addition, a
collection of injected embryos showing no enhancer activity was
grown further to derive stable transgenic lines. Combining the results
from these two experiments allowed us to determine the fraction false
positive and false negative enhancers. Analysis of the stabletransgenic
lines allowed us to identify two different categories of enhancers. A
first category is that of enhancers that drive consistent, tissue-specific
patterns in all the founder lines; a second category is contains
elements that stimulate promoter activity, but the precise patterns
driven differ among founder lines –likely due to extreme sensitivity to
the regulatory information surrounding the insertion point in each
founder line. These two types of enhancers have been already
described when enhancer activity has been monitored in stable
transgenic zebrafish assays [33,34,35]. Finally, we show that a
fraction of the HCNR for which we did not detect enhancer activity
in F0 assays behave as enhancer blockers in vivo.
Materials and Methods
Ethic statement
Zebrafish transgenic fishes have been maintained at the CABD
Animal Facility. Our Animal Facility in accordance with nacional
and European regulations is registered as animal research center with
the number SE/4/U. Veterinary welfare supervision and daily water
check-ups are conducted (dissolved oxygen, conductivity, pH, ammo-
nia, nitrites, nitrates, alkalinity and hardness –Kh and Gh-, among
other parameters) to ensure the animals good health status.
Temperature, humidity and light intensity control in the room are
strictly monitorized to guarantee animal welfare. Zebrafish embryos
have been sacrificed after being anesthetized with 0.016% tricaine
when necessary. The experimental zebrafish procedures have been
performed following the protocols approved by the Ethical Commi-
ttee for Animal Research from Consejo Superior de Investigaciones
(CSIC) according to the European Union regulations.
Animal care
Zebrafish (Danio rerio) were maintained and obtained from our
breeding colony under standard conditions according to previously
stated procedures (http://zfin.org). Embryos for Tol2 transgenesis
were obtained from crosses of wild-type AB/Tuebingen (AB/TU)
zebrafish. Potential transgenic founders were out-crossed to a TAP
strain. Fertilized eggs were kept at 28uC in E3 medium with
0.003% 1-phenyl-2-thiourea to prevent pigmentation and were
staged according to Kimmel et al. [36].
ZED-HCNR Collection
Human HCNR fragments where amplified using HiFi Taq
polymerase (Roche, Manheim, Germany) using standard PCR
procedures. Products where cloned into pCR8/GW/TOPO vector
(Invitrogen, Pasadena, USA). HCNR-containing clones where
recombined into the Zebrafish Enhancer Detection (ZED) shuttle
transgenesis vector previously described [32]. Briefly, ZED-Vector
contains two modules flanked by the Medaka (Oryza latipes) Tol2
transposase target sites, that enables an efficient transgenesis [37].
The first module contains the minimal GATA promoter driving the
expression of the enhanced green fluorescent protein (EGFP). All
HCNRs were cloned upstream of this module using the Gateway
system (Invitrogen, Pasadena, USA). Two strong insulators, which
reduce the potential influence of the regulatory elements that may
be present in the vicinity of the integration sites, flank this reporter
cassette. The second module contains the cardiac actin promoter
driving the expression of the red fluorescent protein (RFP), which
serves as a positive control for transgenesis in F0 and F1 embryos
[32]. The tested HCNRs are listed in Table S1.
Selection of enhancer-containing HCNRs candidates
A minimum of 300 embryos where injected with 3–5 nl of a
solution containing 25 nM of each construct and 25 nM of Tol2
mRNA. Embryos where then incubated at 28uC as previously
described. EGFP expression was evaluated 24, 48 and 72 hours
post-fertilization (hpf). Whenever EGFP was observed, the HCNR
tested was considered as a potential candidate and embryos were
selected and raised to sexual maturity to be analyzed in F1. The
efficiency of the integration of the ZED-HCNR construct in the
injected embryos was determined by the expression of RFP in the
somites and the heart. We only evaluated the enhancer potential of
the HCNRs when RFP was broadly observed in the somites and
the heart of the injected embryos, as an indication of efficient
ZED-HCNR integration. For high-resolution pictures a F-View
black/white digital camera coupled to a WD70 Nikon camera was
used. Adobe Photoshop was used to adjust bright and contrast.
Enhancer-blocking assays
To evaluate in vivo a potential insulator activity of HCNRs,
we used a Tol2 vector previously described [32]. This construct
contains a strong midbrain enhancer, a Gateway entry site and
the cardiac actin promoter controlling the expression of EGFP.
Each candidate HCNR was recombined between the midbrain
enhancer and the cardiac actin promoter (INS-HCNR). As a
reference, the empty backbone was used (INS-zero). One cell-stage
embryos where injected with 3–5 nl of a solution containing
25 nM of each construct plus 25 nM of Tol2 mRNA. Embryos
where then incubated at 28uC and EGFP expression was
evaluated 24 hpf. The midbrain/somites EGFP intensity ratio
was quantified using ImageJ freeware and was directly propor-
tional to the enhancer-blocking capacity. As a positive control, the
chicken beta-globin insulator 5HS4 was used. Each experiment
was repeated independently and double-blinded to the operators.
Results
Enhancer activity of human HCNRs in zebrafish embryos
A total of 113 HCNRs from the human chromosome 16 were
PCR-amplified, transferred to the ZED vector to generate the
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tube Forebrain Midbrain Hindbrain
Otic
vesicle Pronefros Eye Notes
C25 + 32 1 0110 00
C29 + 50 3 0023 40
C30 + 30 1 3332 00
C32 + 30 3 0003 30
C33 + 30 1 2012 00 1 Somites.
C36A + 31 0 0010 00 A t 2 4 h p f .
C40 + 40 1 2012 01
C41 + 30 3 3333 00
C43 + 30 0 0000 00
C44 + 51 2 2220 00
C50A + 31 1 2211 00
C60 + 80 2 4225 01
C61 + 50 0 0000 01 1 Somites at
24 hpf.
C76 + 40 1 1110 01 1 P ectoral fin.
C81 + 30 2 3332 03 1 s o m i t e s a t
24 hpf.
C86 + 50 1 0112 03
C91 + 20 0 0000 00
C96 + 40 1 1001 01
C97 + 70 0 4002 01
C106 + 30 0 0001 01
C107 + 30 0 0000 00 1 H i n d / M i d b r a i n
boundary.
C114 + 20 2 2111 00
C118 + 30 1 0111 00
C121 + 40 0 0112 01
C122 + 30 0 0112 01
C130 + 20 0 0021 00 E x p ression at
24 hpf.
C134A + 70 0 0020 00
C135 + 31 2 0003 00 1 H u t c h i n g
gland.
C137 + 50 4 0020 01
C139 + 30 0 0030 00
C140 + 80 2 1000 00
C141 + 30 0 0030 03
C145 + 20 2 2220 00
C150 + 20 0 0000 00
C153 + 40 2 2023 00
C26 2 30 0 0000 00
C35 2 80 0 2011 11
C52 2 20 0 0000 00
C59 2 40 1 2022 01
C65 2 20 1 0110 00
C78 2 20 0 0000 00 a t 2 4 h , g e n e r a l
expression.
C82 2 22 0 2012 00
C90 2 20 0 0000 00
C99 2 30 0 0100 00
C111C 2 30 0 1000 01 1 g u t .
doi:10.1371/journal.pone.0024824.t001
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embryos (Table S1). Among them, 39 (34%) exhibited mosaic
EGFP expression at 24, 48 and/or 72 hpf in F0 and where
therefore selected for their analysis in F1 stable transgenic lines.
The remaining constructs did not show visible EGFP activity
although clear and homogenous RFP expression in the somites
and heart was observed, indicating an efficient integration of the
cassette. In order to determine the ratio of false negatives, 10
random HCNRs with no apparent F0 EGFP activity were also
raised to sexual maturity and screened for enhancer activity in
stable transgenics. Finally, to determine the likelihood of enhancer
trapping of our reporter cassette, the empty ZED vector without
any cloned HCNR upstream the minimal promoter (ZED-zero)
was also injected and the embryos grown to sexual maturity. Upon
raising and out-crossing the adult fishes, 35 HCNRs were suitable
for analysis. For the remaining ones we only obtained a single
founder that precludes us to unambiguously determine the real
enhancer activity of the HCNR under evaluation. A first analysis
highlighted that approximately 63% of the F0 EGFP
+ HCNRs (22
out of 35) do showed enhancer activity in stable lines. The
expression patterns promoted at different tissues in the different
founders of each HCNR are summarized in Table 1. Among these
22 regions, 9 HCNR showed reproducible expression patterns
among founders (Fig. 1 and Fig. S1). These HCNRs were consi-
dered to contain robust enhancers. The remaining 13 HCNRs
contained enhancers with more variable activity observed between
their corresponding founders (Table 1 and Fig. S2). A similar
proportion between enhancers with robust and variable activities
has been shown before when assaying HCNRs from other
genomic regions [33,34,35]. From these 13 HCNRs, we found
one extreme case in which the different founders showed strong
but largely non-overlapping expression patterns (Fig. 2). This
phenomenon has been traditionally named enhancer trapping.
However, according to the vector design, the two strong insulators
flanking the expression cassette should reduce unspecific EGFP
expression caused by the genomic context in which the integration
occurs. Indeed, among six independent founders containing the
empty ZED vector only two showed some weak position effect
(Fig. S3), which confirmed that our reported construct prevents
strong position effects. Therefore, the HCNR showing multiple
founders with strong but different expression patterns seems likely
overcoming the influence of the insulators of the reporter module
and boosting the enhancer activity of the genomic landscapes
around each particular transgene insertion point. Interestingly, we
have also detected this type of booster activity in other regulatory
regions found within other unrelated HCNR enhancer screens
(unpublished results).
Finally, among the 10 HCNRs that were EGFP
2 in F0 assays
and were surveyed for enhancer activity in F1 stable lines, 8 of
them exhibited only the RFP expression corresponding to the
positive control contained in the vector. However, the remaining
two (C82 and C59; Table 1, Fig. S1 and Fig. S2) did contain
enhancer activity.
Transient versus stable transgenic assays
Many groups use the compilation of the results from several
mosaic transient transgenic embryos to extract the regulatory
potential of a candidate regulatory element, assuming that this
compilation would recapitulate the expression that should be
observed in stable transgenic lines [7,24,29,30,31]. This type of
experimental approximation is particularly interesting given the
fact that most of the effort required for the generation of transgenic
zebrafish animals resides in raising and out crossing the injected
fishes. In our screening, we have documented the enhancer
activity of all HCNRs in F0 injected embryos and generated stable
lines for all potential enhancer regions positive in these transient
assays. This has allowed us to compare the enhancer behavior of
HCNRs in F0 and F1 trasngenic embryos. Our results indicate
that for those HCNRs with reproducible enhancer activity in F1
stable lines, F0 data would be a good predictor for expression
patterns in F1, being always the information obtained from stable
lines more compete (Fig. 3A–D). In contrast, transient F0 are poor
Figure 1. Reproducible enhancer. EGFP expression patterns exhibited from four different founders f(A–D) of the HCNR C32 at 48 hpf. EGFP
expression can be seen in otic vesicle (ov), spinal cord (sc) and pronephros (pr). Fluorescence in the pineal gland (pg) in these and other embryos
shown below correspond to non specific expression observed in most transgenic generated with the ZED vector.
doi:10.1371/journal.pone.0024824.g001
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H). This, along with the fact that F0 negative regions, in some
cases, do show enhancer activity in F1 stable lines, indicate that
conclusions drawn from enhancer analysis in F0 transient assays
may be incomplete and in cases misleading.
Comparison of HCNR enhancer activity in mice and
zebrafish embryos
We have also compare our results with those produced in mice
and available at public databases (http://enhancer.lbl.gov/, [5].
We found 6 human sequences with tissue-specific enhancer
activity in mice that partially overlapped our initial HCNR
collection. Three of them were also detected as enhancers driving
consistent tissue-specific patterns in our zebrafish assays (C81,
C139, C141, table 2). The expression patterns observed in
zebrafish embryos were similar to that observed in mouse embryos
(Fig. 4, Fig. S4 and Fig. S5), suggesting that the transcription
factors required to activate these enhancers are similarly expressed
in both mice and zebrafish.
The other three enhancers active in mice cases were found
negative in our F0 zebrafish assays and therefore not selected for
F1 analysis (C48, C93 and C103). It is possible that, since the exact
sequence included in the constructs for the two experiments was
not the same, sequence differences might account for the different
Figure 3. Reproducible enhancers may be distinguished in F0. Side by side comparison of the expression patterns expected from F0 (left
panels) and the corresponding F1 (right panels). Strongly (A–D), but not weakly (E–H) reproducible enhancers showed a high similarity in transient
(A–H) and stable (A9–H9) transgenic assays. Abbreviations are: notochord (n), branchial arches (ba), otic vesicle (ov), eye (e), forebrain (f), midbrain (m),
hindbrain (h) and spinal cord (sc).
doi:10.1371/journal.pone.0024824.g003
Figure 2. CNR with genomic boosting behaviour. EGFP expression patterns exhibited from six different founders (A–F) from HCNR C60 at
48 hpf. EGFP expression can detected in different territories depending on the founder, suggesting that a transcription pattern largely depending on
the genomic context. Abbreviations are: branchial arches (ba), otic vesicle (ov), eye (e), forebrain (f), midbrain (m), hindbrain (h) and spinal cord (sc).
doi:10.1371/journal.pone.0024824.g002
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behaved as negative in transient but have shown activity if
established as stable lines. Finally, all HCNR detected as enhancer
in zebrafish had been shown to be enhancers in mice as well.
HCNRs negative in enhancer assays may harbor
insulators
Among the different types of cis-regulatory elements, insulators
play key roles in controlling gene expression and organizing the
chromatin [38]. Since many HCNRs did not showed enhancer
activity, we determined if a fraction of them could be associated
with insulators activity. For that we used a recently described
vector [32] that has been used in zebrafish to functionally evaluate
insulator activity in vivo [32,39,40]. We concentrated on 13 HC
NRs lacking enhancer activity in our initial F0 enhancer assays
and located all along 2 Mb covering the Iroquois B (IRXB) genomic
cluster. Interestingly, three of these HCNRs showed a significant
enhancer-blocking activity, ranging between 40–60% blockage
(C75 and C91, respectively. p,10
23, student t-test) (Fig. 5, Table
S2). These data suggest that HCNRs, in addition to harboring
enhancer elements, also contain insulators that regulate enhancer-
promoter interactions.
Discussion
In this report we present a chromosome-wide analysis of
the HCNRs present on human chromosome 16. Among the 113
HCNRs assayed, 35% showed enhancer activity in transient F0
transgenic embryos. Nevertheless, only 60% of them are associated
with detectable enhancer activity in stable (F1) zebrafish transgenic
lines. Only those enhancers showing highly reproducible expression
in F0 transient assays correspond to those that are also highly
reproducible in stable lines. Therefore, F0 assays are only infor-
mative for strong enhancers. Indeed, here we show that 40% of
HNCRs scored positive in F0 transient assays may not be real
enhancers. Most of these regions showed a low number of EGFP
positive cells in the F0 assays, which may indeed reflect positional
effects and not true enhancer activity. In addition, by examining in
stable transgenic lines the activity of a fraction of the regions scored
Figure 4. Enhancer assays in zebrafish allow a detailed spatiotemporal characterization of the expression patterns. A) Illustration of
the first 48 hpf development of the zebrafish (upper panel). In the lower panel, EGFP expression of HCNR C81 during the first 48 hpf. B) Detailed EGFP
expression of the HCNR C81 at 48 hpf. The same CNR was as assayed (Vista browser element37, http://pipeline.lbl.gov/cgi-bin/gateway2).
Abbreviations are: eye (e), forebrain (f), midbrain (m), hindbrain (h) and spinal cord (sc).
doi:10.1371/journal.pone.0024824.g004
Table 2. Comparison of the enhancer activity among the HCNRs assayed in the present study versus those available from VISTA.
VISTA Chr Start End size Activity
Present
Study Chr Start End Size Activity
Overlapping
(bp)
element73 16 50134226 50135602 1376 + C48 16 50134268 50135590 1322 2 1322
element65 16 50515789 50517189 1400 + C55 16 50516006 50516943 937 n.a. 937
element37 16 53208099 53209383 1284 + C81 16 53208063 53209682 1619 + 1284
element27 16 53636738 53637930 1192 + C90 16 53636501 53637749 1248 n.a. 1011
element23 16 53981917 53983239 1322 + C93 16 53981929 53983259 1330 2 1310
element16 16 71538401 71540046 1645 + C109 16 71539086 71539495 409 2 409
element4 16 78930094 78931256 1162 + C139 16 78930617 78931252 635 + 635
element1 16 84987588 84988227 639 + C141 16 84987535 84988024 489 + 436
doi:10.1371/journal.pone.0024824.t002
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enhancer activity. Therefore, at least with our ZED vector and
using human sequences, F0 transient transgenic zebrafish assays
might be unreliable as predictors of enhancer activity, as we detect
40% of false positives and 20% of false negatives. A similar analysis
to that performed here would be recommended for other vectors
commonly used for evaluating enhancers in zebrafish though F0
transient assays to determine their specificity and sensitivity.
We have generated multiple different founders for the 24
enhancers we have identified. This allows us to categorize the
enhancer activity of the HCNRs in two major groups: highly
reproducible enhancers and less specific ones, as previously also
described [33,34,35]. Within the last group, we find one HCNR
with apparently strong booster activity: Different founders for this
region show strong but unrelated expression patterns. This is
something that we have also observed for other enhancers
previously identified (unpublished results). Indeed, this type of
very interesting regions, although barely characterized, has been
previously described for the mice TAL1 gene [41]. In this work, a
mammalian interspersed repetitive element (MIR) was shown to
Figure 5. In vivo enhancer-blocking assay of HCNRs mapping the human IRXB locus. 30 hpf zebrafish injected with the insulator-vector
assay lacking any HCNR (panel A) and C91 (panel B). With no insulator activity, Z48 enhancer interacts with the cardiac actin promoter promoting
EGFP expression to the midbrain (C). Whenever an insulator is placed between the enhancer and the promoter, midbrain expression is reduced when
compared to the somites expression, which remain unaffected. Adapted from Bessa et al, 2009. E) Wisker-plot representation of the midbrain/somite
ratios from different regions tested.
doi:10.1371/journal.pone.0024824.g005
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enhancer and booster drive expression of TAL1 to different
hematopoietic tissues in transgenic mice. The HCNR with booster
activity we now identify is located within a gene desert between
human SALL1 and TOX3 genes. Eight independent founders
provide evidence that this region may be playing a positive role
over transcription, however its physiological role and its target
gene are still unknown.
Cis-regulatory elements include enhancers, silencers, insulators
and likely other unidentified type of sequences [42]. All of these
types of elements could be in principle highly conserved at the
sequence level in the vertebrate lineage [43]. However, to our
knowledge, HCNRs have been only functionally assayed for
enhancer activity. We show that 20% (3 of 13) of the HCNRs
examined, that do not show any enhancer activity in F0 transient
assays, seem to behave as insulators. This strongly indicates that
functions other than enhancer activity is associated also with
highly conserved sequences. We have examined the region
comprising the Iroquois B (IRXB) genomic cluster, an evolutionary
conserved cluster that spans <1.3 Mb of the chromosome that
contains three developmental genes (IRX3, 5 and 6) with multiple
function during development [44]. To be able to exert these
multiple functions, these genes have complex expression patterns
[45,46,47] controlled by multiple cis-regulatory elements spread
all over the cluster, many of them located within HCNRs [6].
These cis-regulatory sequences precisely interact with their
respective target promoters depending on the three-dimensional
looping of the cluster’s chromatin [22]. The IRXB region contains
a significant enrichment of HCNRs when compared to the rest of
the chromosome (2% of the chromosome’s size harboring 20% of
the total HCNRs), which correlates with the highly complex
regulation of the genes within it [6,22]. The high proportion of
sequences with insulator activity in this region may be thus
associated with the complex regulation of the IRXB genes. It
remains to be determined if a similar fraction of insulator also
exists in HCNRs from other chromosomal regions.
Most insulators found in vertebrates are associated with the
DNA binding factor CTCF [48]. When HCNRs with insulator
function where subjected to in silico motif discovery for CTCF,
these sequences exhibited weak scores according to the position
weigh matrix tested. Moreover, the examination of the available
data on the distribution of CTCF in different human cell lines
generated by the ENCODE project [13] and available at the
UCSC browser [49], also indicated that these HCNRs are not
bound by CTCF in those cell lines. Therefore, it is likely that
additional insulator-associated proteins may be responsible for the
enhancer-blocking activity displayed by these sequences.
In summary, our large enhancer screen allows us to show the
different types of enhancer activities within HCNRs, ranging from
very specific and reproducible enhancers to boosters with little
tissue-specificity. In addition, for the first time, we have uncovered
the presence of insulator activity within these conserved sequences.
Many other functions such as some required for chromatin
topology or repressor activities could be also associated to these
HCNRs. Indeed, many HCNRs did not behave either as
enhancers or as insulators in our functional assays. However, the
identification of such activities remains a future challenge.
Supporting Information
Figure S1 Expression patterns associated to HCNRs
containing robust enhancers. Each box contains a series of
pictures showing the expression pattern obtained from different
founders from a single HCNR. Pictures were taken using a black/
white camera with a GFP filter.
(TIF)
Figure S2 Expression patterns associated to HCNRs
with variable enhancer activity. Each box contains a series of
pictures showing the expression pattern obtained from different
founders from a single HCNR. Pictures were taken using a black/
white camera with a GFP filter.
(TIF)
Figure S3 Controls suggest a low enhancer trapping
capacity of the empty ZED vector. Diagram showing the
structure of the ZED vector (A). Transgenic zebrafish evaluated at
48 hpf from six independent founders obtained from the ZED-
zero construct. Pictures evidenced both spurious or no EGFP
expression (B–F), despite strong RFP expression in the somites (G).
Abbreviations: Tol2: Tol2 transposase target site; C. Actin: cardiac
actin promoter; rfp; red fruorescent protein gene; ins: insulator;
gfp: green fluorescent protein gene; Min. Prom: minimal promo-
ter; entry site: gateway entry site, which was eliminated to generate
the ZED-zero construct.
(TIF)
Figure S4 Comparison of the enhancer activity deter-
mined for C139 versus the data available from VISTA
Element-4. Three different founders from zebrafish (A) and mice
(B), obtained upon the evaluation of the enhancer activity of the
human sequence assigned as C139 (A), or Element-4 (B). In panel
C we represent the alignment of both sequences.
(TIF)
Figure S5 Comparison of the enhancer activity deter-
mined for C141 versus the data available from VISTA
Element-1. Three different founders from zebrafish (A) and mice
(B), obtained upon the evaluation of the enhancer activity of the
human sequence assigned as C141 (A), or Element-1 (B). In panel
C we represent the alignment of both sequences.
(TIF)
Table S1 Details of the highly conserved non-coding
regions assayed.
(DOC)
Table S2 In vivo enhancer-blocking assays.
(DOC)
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